Skip to main content
Log in

p53 Expression in four human medulloblastoma-derived cell lines

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

p53 is a tumor suppressor gene found on the short arm of chromosome 17. Loss of onep53 allele and alteration of the other is found in a variety of tumors, including highgrade glial tumors. Point mutations in the remaining allele occur in a highly conserved region of the gene encompassing exons 5–8. Although 40–50% of medulloblastomas lose sequences on the short arm of chromosome 17, alteration ofp53 in these tumors is infrequent. To further characterize genetic alteration ofp53 in medulloblastoma, we performed a mutational analysis of four medulloblastoma-derived cell lines established by our laboratory. Using two variable-number tandem repeat markers which map distally top53, we found evidence indicating loss of sequences on the distal end of chromosome 17 p in all four lines. However, no gross alterations of thep53 gene were detected. Northern analysis revealed expression of equivalent amounts of full-lengthp53 messenger RNA in each cell line. Using the polymerase chain reaction to amplify exons 5–8 of thep53 gene, we directly sequenced the amplified fragments and detected no mutations in any of the cell lines. Our results demonstrate that loss ofp53 function through gene deletion and/or recesive mutation is not required for growth in our cell lines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Biegel JA, Burk CD, Barr F, Emmanuel BS (1992) Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 52:3391–3395

    PubMed  Google Scholar 

  2. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wylie AH (1993) Thymocyte apoptosis induced by p53-dependent and indepent pathways. Nature 363: 849–852

    Google Scholar 

  3. Cogen PH, Daneshvar L, Metzger AK, Edward MSB (1990) Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics 8:279–285

    PubMed  Google Scholar 

  4. Deimling A von, Eibl RH, Ohgaki H, Louis DN, Ammon K von, Peterson I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR (1992) p53 mutations are associated with 17 p allelic loss in grade II and grade III astrocytoma. Cancer Res 52:2987–2990

    PubMed  Google Scholar 

  5. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356:215–221

    Article  PubMed  Google Scholar 

  6. Feinberg AP, Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13

    PubMed  Google Scholar 

  7. Frankel RH, Bayona W, Koslow M, Newcomb EW (1992) p53 mutations in malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 52:1427–1433

    PubMed  Google Scholar 

  8. Hollstein M, Momand J, Finlay CA (1991) The p53 tumor suppressor gene. Nature 351:453–456

    PubMed  Google Scholar 

  9. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427–428

    PubMed  Google Scholar 

  10. Innis MA, Myambo KB, Gelfand DH, Brow MAD (1988) DNA sequencing withThermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA. Proc Natl Acad Sci USA 85:9436–9440

    PubMed  Google Scholar 

  11. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311

    PubMed  Google Scholar 

  12. Keles GE, Berger MS, Lim R, Zaheer A, Denton A, Silber JR (1992) Expression of glial fibrillary acidic protein in human medulloblastoma cells treated with recombinant glial maturation factor-β. Oncol Res 4:431–437

    PubMed  Google Scholar 

  13. Levine AJ (1993) The p53 tumor suppressor gene and product. Biol Chem Hoppe Seyler 374:227–235

    PubMed  Google Scholar 

  14. Levine AJ, Momand J, Finlay CA (1991) The p53 tumor suppressor gene. Nature 351:453–456

    PubMed  Google Scholar 

  15. Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075–3079

    PubMed  Google Scholar 

  16. Lowe S, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 363:847–849

    Google Scholar 

  17. Maltzman W, Czyzyk L (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in non-transformed mouse cells. Mol Cell Biol 4:1689–1694

    PubMed  Google Scholar 

  18. Nakamura Y, Lathrop M, O'Connel P, Leppert M, Barker D, et al (1988) A mapped set of DNA markers for human chromosome 17. Genomics 2:302–309

    PubMed  Google Scholar 

  19. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, et al (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature 342:704–707

    Google Scholar 

  20. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P (1991) p53 mutations in nonastrocytic human brain tumors. Cancer Res 51:6202–6205

    PubMed  Google Scholar 

  21. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplication of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80–83

    PubMed  Google Scholar 

  22. Prives C (1993) Doing the right thing: feedback control and p53. Curr Opin Cell Biol 5:214–218

    PubMed  Google Scholar 

  23. Prives C, Manfredi JJ (1993) The p53 tumor suppressor protein: meeting review. Genes Dev 7:529–534

    PubMed  Google Scholar 

  24. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP (1993) Amplication and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736–2739

    PubMed  Google Scholar 

  25. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

    Google Scholar 

  26. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavenee W, Vogelstein B (1992) Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355:846–847

    PubMed  Google Scholar 

  27. Silber JR, Bobola MS, Ewers TG, Muramoto M, Berger MS (1992) O6-alkylguanine-DNA alkyltransferase is not a major determinant of sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines. Oncol Res 4:241–248

    PubMed  Google Scholar 

  28. Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747–749

    PubMed  Google Scholar 

  29. Wu JK, Zhen Y, Darras BT (1993) Frequency of p53 tumor suppressor gene mutations in human primary brain tumors. Neurosurgery 33:824–831

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Srinivasan, J., Berger, M.S. & Silber, J.R. p53 Expression in four human medulloblastoma-derived cell lines. Child's Nerv Syst 12, 76–80 (1996). https://doi.org/10.1007/BF00819500

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00819500

Key words

Navigation